GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Boiron SA (FRA:BON) » Definitions » Other Operating Expense

Boiron (FRA:BON) Other Operating Expense : €78.7 Mil (TTM As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is Boiron Other Operating Expense?

Boiron's Other Operating Expense for the six months ended in Dec. 2023 was €38.6 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 was €78.7 Mil.

Boiron's quarterly Other Operating Expense declined from Dec. 2022 (€41.9 Mil) to Jun. 2023 (€40.1 Mil) and declined from Jun. 2023 (€40.1 Mil) to Dec. 2023 (€38.6 Mil).

Boiron's annual Other Operating Expense increased from Dec. 2021 (€72.3 Mil) to Dec. 2022 (€80.1 Mil) but then declined from Dec. 2022 (€80.1 Mil) to Dec. 2023 (€78.7 Mil).


Boiron Other Operating Expense Historical Data

The historical data trend for Boiron's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Boiron Other Operating Expense Chart

Boiron Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 79.97 77.20 72.30 80.10 78.68

Boiron Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 35.69 38.16 41.94 40.05 38.63

Boiron Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €78.7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Boiron Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Boiron's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Boiron (FRA:BON) Business Description

Traded in Other Exchanges
Address
2, Avenue de l’Ouest Lyonnais No. 039, Messimy, FRA, 69510
Boiron is a drug manufacturer that focuses on homeopathic products. The company's revenue is roughly split between its nonproprietary homeopathic medicines and products in its over-the-counter specialties category. Boiron's nonproprietary medicines are generic products that do not refer to any therapeutic indication, while the specialties category includes first-resort products provided in tablet form, are bottled to use as drops, syrups, or ointments. Geographical segments are France, Europe, North America, and other countries. It generates a majority of revenue from France. The company's products include Oscillococcinum, Stodal and Stodaline, Arnigel, Camilia, Sedatif PC, Coryzalia, Homeoptic, and Homeovox.